Variance quantitative trait loci reveal gene-gene interactions which alter blood traits

Yash Pershad,Hannah M Poisner,Robert W Corty,Jacklyn N Hellwege,Alexander G Bick

DOI: https://doi.org/10.1101/2024.09.18.24313883

2024-09-19

Abstract:Gene-gene (GxG) interactions play an important role in human genetics, potentially explaining part of the missing heritability of polygenic traits and the variable expressivity of monogenic traits. Many GxG interactions have been identified in model organisms through experimental breeding studies, but they have been difficult to identify in human populations. To address this challenge, we applied two complementary variance QTL (vQTL)-based approaches to identify GxG interactions that contribute to human blood traits and blood-related disease risk. First, we used the previously validated genome-wide scale test for each trait in ~450,000 people in the UK Biobank and identified 4 vQTLs. Genome-wide GxG interaction testing of these vQTLs enabled discovery of novel interactions between (1) CCL24 and CCL26 for eosinophil count and plasma CCL24 and CCL26 protein levels and (2) HLA-DQA1 and HLA-DQB1 for lymphocyte count and risk of celiac disease, both of which replicated in ~140,000 NIH All of Us and ~70,000 Vanderbilt BioVU participants. Second, we used a biologically informed approach to search for vQTL in disease-relevant genes. This approach identified (1) a known interaction for hemoglobin between two pathogenic variants in HFE which cause hereditary hemochromatosis and alters risk of cirrhosis and (2) a novel interaction between the JAK2 46/1 haplotype and a variant on chromosome 14 which modifies platelet count, JAK2 V617F clonal hematopoiesis, and risk of polycythemia vera. This work identifies novel disease-relevant GxG interactions and demonstrates the utility of vQTL-based approaches in identifying GxG interactions relevant to human health at scale.

What problem does this paper attempt to address?

The problem this paper attempts to address is how gene-gene (GxG) interactions affect human blood traits and disease risk. Specifically, the authors utilized the variance quantitative trait loci (vQTL) method to identify several significant GxG interactions in the large-scale population of the UK Biobank. These interactions include:

1. **Eosinophil Count**:
- An interaction between CCL24 and CCL26 was discovered, where the chemokines encoded by these two genes play a crucial role in the recruitment and activation of eosinophils.
- This interaction manifests as an inhibitory effect, meaning that the combined action of the variants of these two genes results in a reduced eosinophil count.

2. **Lymphocyte Count**:
- An interaction between HLA-DQA1 and HLA-DQB1 was found, where these two genes encode part of the MHC class II complex.
- This interaction also exhibits an inhibitory effect and is associated with an increased risk of celiac disease.

3. **Hemoglobin Levels**:
- Several interactions between variants in the HFE gene were identified, which are related to hereditary hemochromatosis.
- Specifically, the rs4645 variant interacts with other variants in HFE, increasing the risk of cirrhosis.

4. **Platelet Count**:
- An interaction between JAK2 and HEATR4 was discovered, affecting platelet count and the risk of polycythemia vera.
- The 46/1 haplotype in JAK2 interacts with variants in HEATR4, reducing the risk of polycythemia vera.

Through these findings, the study demonstrates the effectiveness of the vQTL method in identifying GxG interactions in large-scale populations, aiding in the understanding of how gene interactions influence blood traits and disease risk, thereby advancing the development of personalized medicine.